e-Drug3D 157 |
CHLOROPROCAINE
|
cas 133-16-4 |
CLASS NERVOUS SYSTEM |
ROUTE (list) INJECTION INTRATHECAL OPHTHALMIC |
PK parameters Tmax 0.15 HOUR |
Target TARGET SODIUM CHANNEL |
DrugCentral Sodium channel protein type 10 subunit alpha UNIPROT Q9Y5Y9 SCN10A |
Download SDF file | 2-diethylaminoethyl 4-amino-2-chlorobenzoate Formula: Calculated chemical properties: MW 270.75 NB_atoms 18 XLogP 2.42 PSA 50.487 NB_HD 2 NB_HA 4 fsp3 0.46 Lipinski(0=no;1=yes) 1 |
FDA NDA 009435 (pdf not found) INN (CHLOROPROCAINE HYDROCHLORIDE) NESACAINE (FRESENIUS KABI USA) APPROVAL= AP YEAR= 1955 NDA 087446 (pdf not found) INN (CHLOROPROCAINE HYDROCHLORIDE) CHLOROPROCAINE HYDROCHLORIDE (HOSPIRA) APPROVAL= AP YEAR= 1982 DISCONTINUED NDA 087447 (pdf not found) INN (CHLOROPROCAINE HYDROCHLORIDE) CHLOROPROCAINE HYDROCHLORIDE (HOSPIRA) APPROVAL= AP YEAR= 1982 DISCONTINUED NDA 040273 (pdf not found) INN (CHLOROPROCAINE HYDROCHLORIDE) CHLOROPROCAINE HYDROCHLORIDE (HIKMA) APPROVAL= AP YEAR= 1998 NDA 208791 (pdf not found) INN (CHLOROPROCAINE HYDROCHLORIDE) CLOROTEKAL (B BRAUN MEDICAL) APPROVAL= AP YEAR= 2017 DISCONTINUED NDA 216227 (pdf not found) INN (CHLOROPROCAINE HYDROCHLORIDE) IHEEZO (HARROW EYE) APPROVAL= AP YEAR= 2022 |
Other links: |